BANGJIAN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BANGJIAN Trademark

Serial Number: 79320358 • Registration: 6799705

BANGJIAN is a trademark filed by Shenzhen Biocare Bio-medical Equipment Co., Ltd. on June 21, 2021. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Shenzhen Biocare Bio-medical Equipment Co., Ltd. (3 trademarks)

No. 16-1, Jinhui Road,

Entity Type: 99

Trademark Details

Filing Date

June 21, 2021

Registration Date

July 26, 2022

Published for Opposition

May 10, 2022

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 28, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 7, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 7, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 26, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 26, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 26, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 10, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 20, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2022 NONP
REFUSAL PROCESSED BY IB
Apr 11, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 18, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 18, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 28, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 16, 2021 REPR